ABCLVSPRME• 6 Months (Normalized)
ABCL vs PRME (AbCellera Biologics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABCL Performance $11.41
+223.23%
AbCellera Biologics Inc.
Normalized Baseline0.00%
PRME Performance $3.14
-14.67%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin ABCL LEADS
+237.9%
ABCL outperforming by 237.90%
ABCLPRME
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABCL PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ABCL Price | ABCL Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $11.41 | +223.23% | $3.14 | -14.67% | +237.90% |
| Sep 14, 2026 | $11.17 | +216.43% | $3.18 | -13.59% | +230.02% |
| Sep 11, 2026 | $10.89 | +208.50% | $3.13 | -14.95% | +223.45% |
| Sep 10, 2026 | $10.46 | +196.32% | $3.35 | -8.97% | +205.29% |
| Sep 09, 2026 | $11.05 | +213.03% | $3.47 | -5.71% | +218.74% |
| Sep 08, 2026 | $11.44 | +224.08% | $3.56 | -3.26% | +227.34% |
| Sep 04, 2026 | $11.43 | +223.80% | $3.70 | +0.54% | +223.26% |
| Sep 03, 2026 | $11.57 | +227.76% | $3.71 | +0.82% | +226.94% |
| Sep 02, 2026 | $11.36 | +221.81% | $3.67 | -0.27% | +222.08% |
| Sep 01, 2026 | $11.28 | +219.55% | $3.57 | -2.99% | +222.54% |
| Aug 31, 2026 | $11.48 | +225.21% | $3.59 | -2.45% | +227.66% |
| Aug 28, 2026 | $11.35 | +221.53% | $3.61 | -1.90% | +223.43% |
| Aug 27, 2026 | $12.40 | +251.27% | $3.64 | -1.09% | +252.36% |
| Aug 26, 2026 | $12.24 | +246.74% | $3.58 | -2.72% | +249.46% |
| Aug 25, 2026 | $12.50 | +254.11% | $3.71 | +0.82% | +253.29% |
Page 1 of 9